Volume 22, Number 6—June 2016
Letter
Elevated Pertussis Reporting in Response to 2011–2012 Outbreak, New York City, New York, USA
Robert J. Arciuolo
, Jennifer B. Rosen, and Jane R. Zucker
, Jennifer B. Rosen, and Jane R. Zucker
Table
Provider responses to survey questions related to diagnostic testing for pertussis, New York City, New York, USA*
| Questions and responses | No. (%) |
|---|---|
| Did respondent perform diagnostic tests for pertussis before 2012? | |
| Did not perform diagnostic tests | 282 (66) |
| Performed ≥1 diagnostic test |
147 (34) |
| Which types of diagnostic tests did respondent perform before 2012?† | |
| Bacterial culture | 68 (46) |
| PCR | 66 (45) |
| Serology | 35 (24) |
| DFA |
41 (28) |
| Did respondent change the types of diagnostic tests he/she performed since 2012?‡ | |
| Yes | 52 (12) |
| No | 269 (63) |
| Unknown |
108 (25) |
| Which types of diagnostic tests was respondent more likely to perform since 2012?§ | |
| Bacterial culture | 17 (33) |
| PCR | 33 (63) |
| Serology | 6 (12) |
| DFA | 5 (10) |
| No test |
3 (6) |
| Did respondent change the frequency of diagnostic tests he/she performed since 2012? | |
| More frequent testing | 93 (22) |
| Less frequent testing | 14 (3) |
| Frequency of testing unchanged | 231 (54) |
| No response provided | 1 (<1) |
*N = 429 except as indicated. DFA, direct fluorescent antibody test.
†For 147 respondents who reported performing >1 diagnostic test before 2012. Response choices are not mutually exclusive.
‡For all respondents, including those who reported not performing diagnostic tests before 2012.
§For 52 respondents who reported a change in type of diagnostic test performed since 2012. Response choices are not mutually exclusive.
Page created: May 17, 2016
Page updated: May 17, 2016
Page reviewed: May 17, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.